Home/Filings/4/0001209191-13-048778
4//SEC Filing

MACROGENICS INC 4

Accession 0001209191-13-048778

$MGNXCIK 0001125345operating

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 8:24 PM ET

Size

44.6 KB

Accession

0001209191-13-048778

Insider Transaction Report

Form 4
Period: 2013-10-16
Transactions
  • Conversion

    Series B Convertible Preferred Stock

    2013-10-1610,131,8560 total(indirect: See Footnote)
    Common Stock (615,284 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-162,4480 total(indirect: See Footnote)
    Common Stock (2,448 underlying)
  • Conversion

    Common Stock

    2013-10-16+962,819962,819 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+32,6711,906,268 total(indirect: See Footnote)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2013-10-1612,001,0000 total(indirect: See Footnote)
    Common Stock (962,819 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2013-10-165,547,6110 total(indirect: See Footnote)
    Common Stock (295,494 underlying)
  • Conversion

    Common Stock

    2013-10-16+2,4481,908,716 total(indirect: See Footnote)
  • Exercise of In-Money

    Series D-2 Convertible Preferred Stock Warrant to buy

    2013-10-1646,0050 total(indirect: See Footnote)
    Exercise: $12.24Exp: 2013-10-16Series D-2 Convertible Preferred Stock (2,448 underlying)
  • Conversion

    Common Stock

    2013-10-16+615,2841,578,103 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+295,4941,873,597 total(indirect: See Footnote)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-16613,4020 total(indirect: See Footnote)
    Common Stock (32,671 underlying)
Transactions
  • Conversion

    Common Stock

    2013-10-16+2,4481,908,716 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+962,819962,819 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+615,2841,578,103 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+32,6711,906,268 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2013-10-1610,131,8560 total(indirect: See Footnote)
    Common Stock (615,284 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2013-10-165,547,6110 total(indirect: See Footnote)
    Common Stock (295,494 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-16613,4020 total(indirect: See Footnote)
    Common Stock (32,671 underlying)
  • Exercise of In-Money

    Series D-2 Convertible Preferred Stock Warrant to buy

    2013-10-1646,0050 total(indirect: See Footnote)
    Exercise: $12.24Exp: 2013-10-16Series D-2 Convertible Preferred Stock (2,448 underlying)
  • Conversion

    Common Stock

    2013-10-16+295,4941,873,597 total(indirect: See Footnote)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2013-10-1612,001,0000 total(indirect: See Footnote)
    Common Stock (962,819 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-162,4480 total(indirect: See Footnote)
    Common Stock (2,448 underlying)
Transactions
  • Conversion

    Common Stock

    2013-10-16+32,6711,906,268 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2013-10-1610,131,8560 total(indirect: See Footnote)
    Common Stock (615,284 underlying)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2013-10-1612,001,0000 total(indirect: See Footnote)
    Common Stock (962,819 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2013-10-165,547,6110 total(indirect: See Footnote)
    Common Stock (295,494 underlying)
  • Conversion

    Common Stock

    2013-10-16+962,819962,819 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+615,2841,578,103 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+295,4941,873,597 total(indirect: See Footnote)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-162,4480 total(indirect: See Footnote)
    Common Stock (2,448 underlying)
  • Conversion

    Common Stock

    2013-10-16+2,4481,908,716 total(indirect: See Footnote)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-16613,4020 total(indirect: See Footnote)
    Common Stock (32,671 underlying)
  • Exercise of In-Money

    Series D-2 Convertible Preferred Stock Warrant to buy

    2013-10-1646,0050 total(indirect: See Footnote)
    Exercise: $12.24Exp: 2013-10-16Series D-2 Convertible Preferred Stock (2,448 underlying)
Transactions
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-16613,4020 total(indirect: See Footnote)
    Common Stock (32,671 underlying)
  • Exercise of In-Money

    Series D-2 Convertible Preferred Stock Warrant to buy

    2013-10-1646,0050 total(indirect: See Footnote)
    Exercise: $12.24Exp: 2013-10-16Series D-2 Convertible Preferred Stock (2,448 underlying)
  • Conversion

    Common Stock

    2013-10-16+295,4941,873,597 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+2,4481,908,716 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+615,2841,578,103 total(indirect: See Footnote)
  • Conversion

    Series C Convertible Preferred Stock

    2013-10-165,547,6110 total(indirect: See Footnote)
    Common Stock (295,494 underlying)
  • Conversion

    Common Stock

    2013-10-16+32,6711,906,268 total(indirect: See Footnote)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2013-10-1612,001,0000 total(indirect: See Footnote)
    Common Stock (962,819 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-162,4480 total(indirect: See Footnote)
    Common Stock (2,448 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2013-10-1610,131,8560 total(indirect: See Footnote)
    Common Stock (615,284 underlying)
  • Conversion

    Common Stock

    2013-10-16+962,819962,819 total(indirect: See Footnote)
Transactions
  • Conversion

    Common Stock

    2013-10-16+32,6711,906,268 total(indirect: See Footnote)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2013-10-1612,001,0000 total(indirect: See Footnote)
    Common Stock (962,819 underlying)
  • Exercise of In-Money

    Series D-2 Convertible Preferred Stock Warrant to buy

    2013-10-1646,0050 total(indirect: See Footnote)
    Exercise: $12.24Exp: 2013-10-16Series D-2 Convertible Preferred Stock (2,448 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-16613,4020 total(indirect: See Footnote)
    Common Stock (32,671 underlying)
  • Conversion

    Common Stock

    2013-10-16+615,2841,578,103 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+295,4941,873,597 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+2,4481,908,716 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2013-10-1610,131,8560 total(indirect: See Footnote)
    Common Stock (615,284 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-162,4480 total(indirect: See Footnote)
    Common Stock (2,448 underlying)
  • Conversion

    Common Stock

    2013-10-16+962,819962,819 total(indirect: See Footnote)
  • Conversion

    Series C Convertible Preferred Stock

    2013-10-165,547,6110 total(indirect: See Footnote)
    Common Stock (295,494 underlying)
Transactions
  • Conversion

    Common Stock

    2013-10-16+962,819962,819 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+615,2841,578,103 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+32,6711,906,268 total(indirect: See Footnote)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2013-10-1612,001,0000 total(indirect: See Footnote)
    Common Stock (962,819 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2013-10-165,547,6110 total(indirect: See Footnote)
    Common Stock (295,494 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-16613,4020 total(indirect: See Footnote)
    Common Stock (32,671 underlying)
  • Conversion

    Common Stock

    2013-10-16+295,4941,873,597 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+2,4481,908,716 total(indirect: See Footnote)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-162,4480 total(indirect: See Footnote)
    Common Stock (2,448 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2013-10-1610,131,8560 total(indirect: See Footnote)
    Common Stock (615,284 underlying)
  • Exercise of In-Money

    Series D-2 Convertible Preferred Stock Warrant to buy

    2013-10-1646,0050 total(indirect: See Footnote)
    Exercise: $12.24Exp: 2013-10-16Series D-2 Convertible Preferred Stock (2,448 underlying)
Transactions
  • Conversion

    Series C Convertible Preferred Stock

    2013-10-165,547,6110 total(indirect: See Footnote)
    Common Stock (295,494 underlying)
  • Exercise of In-Money

    Series D-2 Convertible Preferred Stock Warrant to buy

    2013-10-1646,0050 total(indirect: See Footnote)
    Exercise: $12.24Exp: 2013-10-16Series D-2 Convertible Preferred Stock (2,448 underlying)
  • Conversion

    Common Stock

    2013-10-16+32,6711,906,268 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+2,4481,908,716 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2013-10-1610,131,8560 total(indirect: See Footnote)
    Common Stock (615,284 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-16613,4020 total(indirect: See Footnote)
    Common Stock (32,671 underlying)
  • Conversion

    Common Stock

    2013-10-16+615,2841,578,103 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+295,4941,873,597 total(indirect: See Footnote)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2013-10-1612,001,0000 total(indirect: See Footnote)
    Common Stock (962,819 underlying)
  • Conversion

    Common Stock

    2013-10-16+962,819962,819 total(indirect: See Footnote)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-162,4480 total(indirect: See Footnote)
    Common Stock (2,448 underlying)
CASH HARVEY B
10% Owner
Transactions
  • Conversion

    Common Stock

    2013-10-16+615,2841,578,103 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+2,4481,908,716 total(indirect: See Footnote)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-16613,4020 total(indirect: See Footnote)
    Common Stock (32,671 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-162,4480 total(indirect: See Footnote)
    Common Stock (2,448 underlying)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2013-10-1612,001,0000 total(indirect: See Footnote)
    Common Stock (962,819 underlying)
  • Conversion

    Series B Convertible Preferred Stock

    2013-10-1610,131,8560 total(indirect: See Footnote)
    Common Stock (615,284 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2013-10-165,547,6110 total(indirect: See Footnote)
    Common Stock (295,494 underlying)
  • Conversion

    Common Stock

    2013-10-16+962,819962,819 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+295,4941,873,597 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+32,6711,906,268 total(indirect: See Footnote)
  • Exercise of In-Money

    Series D-2 Convertible Preferred Stock Warrant to buy

    2013-10-1646,0050 total(indirect: See Footnote)
    Exercise: $12.24Exp: 2013-10-16Series D-2 Convertible Preferred Stock (2,448 underlying)
Transactions
  • Conversion

    Common Stock

    2013-10-16+962,819962,819 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+615,2841,578,103 total(indirect: See Footnote)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-162,4480 total(indirect: See Footnote)
    Common Stock (2,448 underlying)
  • Conversion

    Common Stock

    2013-10-16+295,4941,873,597 total(indirect: See Footnote)
  • Conversion

    Series A-1 Convertible Preferred Stock

    2013-10-1612,001,0000 total(indirect: See Footnote)
    Common Stock (962,819 underlying)
  • Conversion

    Series C Convertible Preferred Stock

    2013-10-165,547,6110 total(indirect: See Footnote)
    Common Stock (295,494 underlying)
  • Conversion

    Common Stock

    2013-10-16+32,6711,906,268 total(indirect: See Footnote)
  • Conversion

    Common Stock

    2013-10-16+2,4481,908,716 total(indirect: See Footnote)
  • Conversion

    Series B Convertible Preferred Stock

    2013-10-1610,131,8560 total(indirect: See Footnote)
    Common Stock (615,284 underlying)
  • Exercise of In-Money

    Series D-2 Convertible Preferred Stock Warrant to buy

    2013-10-1646,0050 total(indirect: See Footnote)
    Exercise: $12.24Exp: 2013-10-16Series D-2 Convertible Preferred Stock (2,448 underlying)
  • Conversion

    Series D-2 Convertible Preferred Stock

    2013-10-16613,4020 total(indirect: See Footnote)
    Common Stock (32,671 underlying)
Footnotes (10)
  • [F1]Each share of Series A-1 Convertible Preferred Stock converted into approximately 0.0802 of a share of Common Stock without payment of further consideraton upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F10]Immediately.
  • [F2]These securities are held as follows: 928,647 by InterWest Partners VIII, LP ("IW8"), 7,521 by InterWest Investors VIII, LP ("II8") and 26,651 by InterWest Investors Q VIII, LP ("IIQ8") (collectively, the "InterWest Funds"). InterWest Management Partners VIII, LLC ("IMP8") is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.
  • [F3]Each share of Series B Convertible Preferred Stock converted into approximately 0.0607 of a share of Common Stock without payment of further consideraton upon closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F4]These securities are held as follows: 593,566 by IW8, 4,737 by II8 and 16,981 by IIQ8. IMP8 is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.
  • [F5]Each share of Series C Convertible Preferred Stock and each share of Series D-2 Convertible Preferred Stock converted into approximately 0.0533 of a share of Common Stock without payment of further consideraton upon closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F6]These securities are held as follows: 285,064 by IW8, 2,275 by II8 and 8,155 by IIQ8. IMP8 is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.
  • [F7]These securities are held as follows: 31,519 by IW8, 251 by II8 and 901 by IIQ8. IMP8 is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.
  • [F8]Upon exercise, each Series D-2 Convertible Preferred Warrant converted into an equal number of shares of Series D-2 Convertible Preferred Stock. Had the warrants not been exercised, they would have expired upon the closing of the initial public offering. Upon the closing of the Issuer's initial public offering each share of Series D-2 Convertible Preferred Stock then converted into approximately 0.0533 of a share of Common Stock without payment of further consideration. The shares of Series D-2 Convertible Preferred Stock had no expiration date.
  • [F9]These securities are held as follows: 2,363 by IW8, 18 by II8 and 67 by IIQ8. IMP8 is the General Partner of IW8, II8 and IIQ8 and has sole voting and investment control over the shares owned by IW8, II8 and IIQ8. Harvey B. Cash, Philip T. Gianos, W. Scott Hedrick, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are Managing Directors of IMP8 and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein.

Issuer

MACROGENICS INC

CIK 0001125345

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001125345

Filing Metadata

Form type
4
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 8:24 PM ET
Size
44.6 KB